Tentech announced its participation in ‘Dubai Derma 2025’ from April 14 to 16 at the Dubai World Trade Centre, as part of its expand into the Middle Eastern and global markets.

As the largest dermatology and aesthetic medicine exhibition in the Middle East and North Africa, this year, over 1,500 brands from more than 112 countries are expected to participate.

The annual event, which brings together dermatologists and medical device companies from around the world, has established itself as a global business platform for sharing the latest technologies and trends.

At this year’s exhibition, Tentech showcased a diverse range of aesthetic devices, including 10THERMA (Black), 10TRIPLE, 10REVIV, 10LUX, 10MATRIX, and 10LONG. Tentech aims to strengthen its global buyer network and directly highlight the competitive advantages of its product lineup.

In particular, Tentech’s monopolar RF device, 10THERMA, has achieved cumulative sales of over 900 units, approximately 600 units sold domestically and 300 units internationally, demonstrating strong and sustained growth in the global market.

Last year, Tentech obtained medical device certification from the Ministry of Health (MoH) of the United Arab Emirates (UAE), establishing a strong foothold for entry into the Middle Eastern market.

At the same time, Tentech’s 10THERMA has received certifications from major medical regulatory authorities in key global markets, including the USA (FDA), Taiwan (TFDA), Vietnam (MoH), Indonesia (MoH), Thailand (TFDA), Saudi Arabia (SFDA), UAE (MoHAP), and Brazil (ANVISA), further validating its recognized safety and reliability on the international stage.

“We had productive meetings with global buyers at KIMES 2025, with particularly strong interest in 10THERMA,” a Tentech representative said. “At Dubai Derma, our focus will be on expanding strategic partnerships across the Middle East and North Africa.”

Meanwhile, Tentech has been steadily expanding its brand presence in the European and North American markets, participating in events such as IMCAS Paris 2025 in France and the AAD (American Academy of Dermatology) conference earlier this year.

This is part of Tentech’s strategy to strengthen its position in the global medical aesthetic market, extending beyond Asia.